Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank89
3Y CAGR+47.7%
5Y CAGR+44.0%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+47.7%/yr
vs +19.7%/yr prior
5Y CAGR
+44.0%/yr
Recent acceleration
Acceleration
+28.0pp
Accelerating
Percentile
P89
Within normal range
vs 5Y Ago
6.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$1.14B-20.8%
2024$1.43B+125.8%
2023$635.35M+80.4%
2022$352.18M+0.3%
2021$351.01M+91.3%
2020$183.44M+40.7%
2019$130.38M-23.9%
2018$171.41M+999.0%
2017$15.60M+23.8%
2016$12.60M-